3-palmitoylcatechin has been researched along with Liver Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perrissoud, D | 1 |
| Dumont, JM; Maignan, MF; Perrissoud, D | 1 |
1 trial(s) available for 3-palmitoylcatechin and Liver Dysfunction
| Article | Year |
|---|---|
The development of cianidanol and 3-palmitoyl-(+)-catechin as drugs for the treatment of liver diseases.
Topics: Animals; Benzopyrans; Catechin; Clinical Trials as Topic; Dogs; Drug Evaluation, Preclinical; Hepatitis, Viral, Human; Humans; Liver Diseases; Papio; Rabbits; Rats; Tissue Distribution | 1986 |
1 other study(ies) available for 3-palmitoylcatechin and Liver Dysfunction
| Article | Year |
|---|---|
Antinecrotic effect of 3-palmitoyl-(+)-catechin against liver damage induced by galactosamine or ethanol in the rat.
Topics: Animals; Benzopyrans; Catechin; Chemical and Drug Induced Liver Injury; Ethanol; Galactosamine; Hypoxia; Liver Diseases; Male; Necrosis; Rats; Rats, Inbred Strains | 1985 |